PEPFAR HIV Testing, New Treatments, and PrEP Enrollments Fall Sharply After US Aid Cuts
Updated
Updated · Vox.com · Apr 29
PEPFAR HIV Testing, New Treatments, and PrEP Enrollments Fall Sharply After US Aid Cuts
5 articles · Updated · Vox.com · Apr 29
Official data for Q4 2025 show 4 million fewer HIV tests, a 16% drop in new treatments, and a 41% decline in PrEP enrollments across nine countries after the Trump administration's foreign aid reductions.
While HIV treatment for existing patients remained stable at about 20 million, prevention and outreach programs suffered major setbacks, with workforce reductions and outreach to key populations collapsing.
Experts warn that these declines threaten long-term epidemic control, especially among high-risk groups, and that reduced data transparency may obscure emerging crises in affected regions.
With HIV prevention programs collapsing, is the world facing a hidden AIDS resurgence?
How will the loss of decades of HIV data impact future pandemic responses?
A new injectable can stop HIV. Will crumbling health programs prevent its rollout?
Why are some African nations rejecting new US health deals despite needing aid?
What is the true cost of shifting from global aid to 'America First' health deals?